# #144 RSV & What Makes Vaccine Trials Different: Beyond Journal Club on the RENOIR and AReSVi Trials

An episode of [Core IM | Internal Medicine Podcast](https://invisiblenetwork.ai/podcast/1297791208), 31 Jan 2024, 23 min.

Audio: https://pscrb.fm/rss/p/audio2.redcircle.com/episodes/471a0b33-adfe-4ddf-a574-ab107f68b593/stream.mp3

How do you counsel patients eligible for the RSV vaccines? What do the results of the RENOIR and AReSVi trials tell us and how do they compare? How should we interpret vaccine trials in the first place? Tune in to the fourth episode of Beyond Journal Club, a new series brought to you by Core IM in collaboration with NEJM Group. Sponsor: Pathway FREE evidence-based clinical decision support app. Guideline summaries, interactive algorithms, landmark trials & more Show Notes & Transcript Time Stamps: (02:30) | Epidemiology of RSV (03:46) | Development of RSV vaccine (05:55) | Vaccine trial design (12:22) | ARESVI and RENOIR Trials (18:18) | Who should we recommend the RSV vaccine to? (19:50) | What don’t we know? Tags: IMCore, CoreIM, primary care, infectious disease, nurse practitioner, pharmacist, physician assistant Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840 Our Sponsors: * Check out Eko: https://ekohealth.com * Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.